Search

Julie A Friedland

from Kent, WA
Age ~63
Get Report
Also known as:
Julie A Ballard, Juliea Ballard
Phone and address:
26411 107Th Ave SE, Kent, WA 98031
(253) 852-7808
Related to:
Zachary Yovella, 27Anthony J Yovella
Connected to:
Amanda L Friedl, 50Ana M Friedlander, 59Anna Friedland, 127Anne L Friedlander, 59Ariel Friedlander, 63Bradley A Friedlander, 74Brook N Friedlander, 47Bruce A Friedlander, 66Cameron L Friedlander, 49Charlene Friedlander, 43

Julie Friedland Phones & Addresses

  • 26411 107Th Ave SE, Kent, WA 98031 (253) 852-7808
  • 18 Brookland Farms Rd, Poughkeepsie, NY 12601
  • Metairie, LA
  • Nashua, NH
  • Arlington, MA
  • Waltham, MA
  • State College, PA
  • Kiona, WA

Work

Company: Brooklake christian school Position: Teacher

Industries

Religious Institutions

Resumes

Resumes

Julie Friedland Photo 1

Teacher

View page
Location:
Kent, WA
Industry:
Religious Institutions
Work:
Brooklake Christian School
Teacher

Publications

Us Patents

Combination Therapy Of Hsp90 Inhibitory Compounds With Proteasome Inhibitors

View page
US Patent:
20130331357, Dec 12, 2013
Filed:
Jan 10, 2012
Appl. No.:
13/979017
Inventors:
David Proia - Newton MA, US
Julie Friedland - Burlington MA, US
Assignee:
SYNTA PHARMACEUTICALS CORP. - Lexington MA
International Classification:
A61K 31/4196
A61K 31/69
A61K 31/675
US Classification:
514 64, 514384, 514 80, 514383
Abstract:
A composition comprising a proteasome inhibitor, and an Hsp90 inhibitor according to the following formulae (I) or (Ia), a tautomer, or a pharmaceutically acceptable salt thereof, wherein the variables in the structural formulae are defined herein. Also provided are methods for treating a proliferative disorder such as cancer in a subject in need thereof, using pharmaceutical combinations described herein.

Combination Cancer Therapy With An Hsp90 Inhibitor And An Antimetabolite

View page
US Patent:
20140296176, Oct 2, 2014
Filed:
Aug 17, 2012
Appl. No.:
14/239676
Inventors:
David Proia - Newton MA, US
Julie Friedland - Burlington MA, US
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
A61K 31/675
A61K 31/7076
A61N 5/10
A61K 31/519
A61K 31/4196
A61K 31/7068
A61K 31/513
US Classification:
514 45, 514 49, 514274, 514249, 5142651, 514 80, 600 1
Abstract:
The invention provides a method of treating a subject with cancer, particularly leukemia, lymphoma, solid cancer such as colorectal cancer, gastric cancer, bladder cancer, non-small cell lung cancer, and breast cancer, comprising administering to the subject a compound of formulae (I) 40 or (Ia) in combination with an antimetabolite such as methotrexate, pemetrexed, cytarabine or nelarabine, or 5-fluorouracil, or capecitabine or their derivatives.
Control profile
Julie A Friedland from Kent, WA, age ~63 Get Report